Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 ADRA1D [6] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion D00680 Methylergometrine [3] 118, 280, 288
2 ADRA1D [6] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion D08207 Methylergometrine [3] 118, 280, 288
3 ADRA1B [6] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion D00680 Methylergometrine [3] 118, 280, 288
4 ADRA1B [6] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion D08207 Methylergometrine [3] 118, 280, 288
5 ADRA1A [7] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion D00680 Methylergometrine [3] 118, 280, 288
6 ADRA1A [7] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion D08207 Methylergometrine [3] 118, 280, 288
7 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00680 Methylergometrine [3] 118, 280, 288
8 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08207 Methylergometrine [3] 118, 280, 288
9 ADRA2B [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00680 Methylergometrine [3] 118, 280, 288
10 ADRA2B [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08207 Methylergometrine [3] 118, 280, 288
11 ADRA2C [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00680 Methylergometrine [3] 118, 280, 288
12 ADRA2C [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08207 Methylergometrine [3] 118, 280, 288
13 F8 [1] Complement and coagulation cascades D00291 Desmopressin [1] 288
14 F8 [1] Complement and coagulation cascades D02235 Desmopressin [1] 288
15 F9 [1] Complement and coagulation cascades D10821 Emicizumab [1] 288
16 F10 [1] Complement and coagulation cascades D10821 Emicizumab [1] 288
17 NR3C1 [1] Neuroactive ligand-receptor interaction D00473 Prednisone [4] 288, 299, 300, 331
18 SERPIND1 [1] Complement and coagulation cascades D08547 Sulodexide [1] 288
19 HMGCR [4] Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion D00434 Simvastatin [21] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
20 IL11RA [3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage D05266 Oprelvekin [2] 96, 288
21 SERPINC1 [1] Complement and coagulation cascades D08547 Sulodexide [1] 288
22 PLG [4] Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A D01136 Tranexamic acid [6] 46, 70, 215, 227, 288, 299
23 AVPR2 [3] Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D00291 Desmopressin [6] 6, 64, 72, 75, 225, 288
24 AVPR2 [3] Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D02235 Desmopressin [6] 6, 64, 72, 75, 225, 288
25 PSMB5 [8] Proteasome, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03150 Bortezomib [16] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331
26 MS4A1 [1] Hematopoietic cell lineage D02994 Rituximab [4] 288, 296, 300, 331